Global ?-Aminobutyric Acid Receptor Agonists Market Growth (Status and Outlook) 2026-2032
The global ?-Aminobutyric Acid Receptor Agonists market size is predicted to grow from US$ 2847 million in 2025 to US$ 4329 million in 2032; it is expected to grow at a CAGR of 5.9% from 2026 to 2032.
?-Aminobutyric Acid Receptor Agonists are pharmaceutical agents that produce therapeutic effects primarily by activating GABA receptors or by generating clinically relevant GABA-B receptor-related agonist activity. Commercial products mainly include baclofen oral tablets, oral suspensions, granules, and intrathecal injections, immediate-release and extended-release sodium oxybate formulations, mixed oxybate salt oral solutions, and a limited number of regionally approved phenibut medicines. By enhancing inhibitory neurotransmission in the central nervous system, these products reduce neuronal excitability and are mainly used for central spasticity associated with multiple sclerosis, spinal cord injury, and other neurological disorders, as well as for narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and selected regional neuropsychiatric indications. Key upstream inputs include baclofen, sodium oxybate, mixed mineral oxybate salts, phenibut, pharmaceutical-grade excipients, controlled-release polymers, flavoring agents, water for injection, sterile filtration materials, glass containers, and specialized pharmaceutical packaging. Major downstream customers include hospitals, neurology and neurosurgery departments, rehabilitation centers, sleep medicine centers, psychiatric institutions, specialty pharmacies, pharmaceutical distributors, and retail pharmacies. The estimated industry gross margin generally ranges from approximately 70% to 82%, with branded oxybate products and differentiated specialty formulations positioned toward the upper end of the range and conventional baclofen generics and regional prescription products positioned toward the lower end.
The global ?-Aminobutyric Acid Receptor Agonists market has a two-tier structure characterized by concentrated high-value specialty medicines and fragmented mature generic products. Oxybate medicines are primarily used for narcolepsy and idiopathic hypersomnia and account for most industry revenue because of their relatively high annual treatment value, specialized prescribing requirements, and controlled distribution systems. Baclofen products are widely used for central spasticity, while conventional oral formulations have entered a mature generic stage with numerous regional suppliers. Competition in the conventional segment mainly centers on supply reliability, registration coverage, hospital access, procurement pricing, and manufacturing cost control. Intrathecal baclofen and differentiated oral formulations remain more concentrated because of their higher requirements for sterile production, dose control, specialist administration, and long-term patient management.
From a product development perspective, oxybate medicines are evolving from traditional high-sodium and multiple-dose nightly regimens toward low-sodium formulations, extended-release delivery, and reduced dosing frequency. Product differentiation is increasingly focused on dosing convenience, sleep maintenance, next-day function, sodium burden, safety management, and patient adherence rather than on efficacy alone. Development in the baclofen segment is concentrated in high-concentration oral suspensions, granules, swallow-friendly liquid formulations, and multi-strength sterile injections designed for intrathecal infusion. These formulation improvements address the needs of pediatric patients, patients with swallowing difficulties, individuals requiring precise dose titration, and patients with severe treatment-resistant spasticity. Overall, technological progress is driven more by formulation optimization, administration convenience, and specialist treatment integration than by replacement of the underlying pharmacological mechanism.
Market growth is supported by improving diagnosis of narcolepsy, idiopathic hypersomnia, and severe neurological spasticity, as well as by the expansion of sleep medicine, neurology, rehabilitation, and specialist pharmacy networks. Narcolepsy and idiopathic hypersomnia remain underdiagnosed or are often diagnosed after prolonged delays, leaving additional treatment demand to be released as physician awareness, referral pathways, and patient education improve. Severe spasticity also creates sustained demand for individualized and long-term treatment, supporting continued use of intrathecal baclofen and differentiated oral formulations. Broader reimbursement coverage, improved commercial insurance access, and stronger specialist treatment infrastructure may further increase patient access to high-value products. In emerging markets, demand growth is expected to rely more heavily on generic baclofen availability, hospital coverage, and improvements in neurological care capacity.
The industry nevertheless faces significant regulatory, pricing, and substitution risks. Oxybate medicines are controlled central nervous system products and require strict prescribing, risk management, specialist distribution, and patient monitoring, which limits rapid expansion through conventional channels. The entry of authorized and conventional generics is expected to improve treatment access but will place downward pressure on the pricing and market share of established branded products. Conventional baclofen formulations face product commoditization, centralized procurement, and low-price competition, while intrathecal therapy remains constrained by procedure complexity and the availability of trained treatment centers. In the longer term, orexin receptor agonists, other wake-promoting medicines, and new treatment approaches for spasticity may divert part of existing demand. Competitive advantage will therefore increasingly depend on differentiated formulations, clinical evidence, reimbursement access, specialist distribution, supply reliability, and patient-management capabilities.
LPI (LP Information)' newest research report, the “?-Aminobutyric Acid Receptor Agonists Industry Forecast” looks at past sales and reviews total world ?-Aminobutyric Acid Receptor Agonists sales in 2025, providing a comprehensive analysis by region and market sector of projected ?-Aminobutyric Acid Receptor Agonists sales for 2026 through 2032. With ?-Aminobutyric Acid Receptor Agonists sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ?-Aminobutyric Acid Receptor Agonists industry.
This Insight Report provides a comprehensive analysis of the global ?-Aminobutyric Acid Receptor Agonists landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on ?-Aminobutyric Acid Receptor Agonists portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ?-Aminobutyric Acid Receptor Agonists market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ?-Aminobutyric Acid Receptor Agonists and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ?-Aminobutyric Acid Receptor Agonists.
This report presents a comprehensive overview, market shares, and growth opportunities of ?-Aminobutyric Acid Receptor Agonists market by product type, application, key players and key regions and countries.
?-Aminobutyric Acid Receptor Agonists are pharmaceutical agents that produce therapeutic effects primarily by activating GABA receptors or by generating clinically relevant GABA-B receptor-related agonist activity. Commercial products mainly include baclofen oral tablets, oral suspensions, granules, and intrathecal injections, immediate-release and extended-release sodium oxybate formulations, mixed oxybate salt oral solutions, and a limited number of regionally approved phenibut medicines. By enhancing inhibitory neurotransmission in the central nervous system, these products reduce neuronal excitability and are mainly used for central spasticity associated with multiple sclerosis, spinal cord injury, and other neurological disorders, as well as for narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and selected regional neuropsychiatric indications. Key upstream inputs include baclofen, sodium oxybate, mixed mineral oxybate salts, phenibut, pharmaceutical-grade excipients, controlled-release polymers, flavoring agents, water for injection, sterile filtration materials, glass containers, and specialized pharmaceutical packaging. Major downstream customers include hospitals, neurology and neurosurgery departments, rehabilitation centers, sleep medicine centers, psychiatric institutions, specialty pharmacies, pharmaceutical distributors, and retail pharmacies. The estimated industry gross margin generally ranges from approximately 70% to 82%, with branded oxybate products and differentiated specialty formulations positioned toward the upper end of the range and conventional baclofen generics and regional prescription products positioned toward the lower end.
The global ?-Aminobutyric Acid Receptor Agonists market has a two-tier structure characterized by concentrated high-value specialty medicines and fragmented mature generic products. Oxybate medicines are primarily used for narcolepsy and idiopathic hypersomnia and account for most industry revenue because of their relatively high annual treatment value, specialized prescribing requirements, and controlled distribution systems. Baclofen products are widely used for central spasticity, while conventional oral formulations have entered a mature generic stage with numerous regional suppliers. Competition in the conventional segment mainly centers on supply reliability, registration coverage, hospital access, procurement pricing, and manufacturing cost control. Intrathecal baclofen and differentiated oral formulations remain more concentrated because of their higher requirements for sterile production, dose control, specialist administration, and long-term patient management.
From a product development perspective, oxybate medicines are evolving from traditional high-sodium and multiple-dose nightly regimens toward low-sodium formulations, extended-release delivery, and reduced dosing frequency. Product differentiation is increasingly focused on dosing convenience, sleep maintenance, next-day function, sodium burden, safety management, and patient adherence rather than on efficacy alone. Development in the baclofen segment is concentrated in high-concentration oral suspensions, granules, swallow-friendly liquid formulations, and multi-strength sterile injections designed for intrathecal infusion. These formulation improvements address the needs of pediatric patients, patients with swallowing difficulties, individuals requiring precise dose titration, and patients with severe treatment-resistant spasticity. Overall, technological progress is driven more by formulation optimization, administration convenience, and specialist treatment integration than by replacement of the underlying pharmacological mechanism.
Market growth is supported by improving diagnosis of narcolepsy, idiopathic hypersomnia, and severe neurological spasticity, as well as by the expansion of sleep medicine, neurology, rehabilitation, and specialist pharmacy networks. Narcolepsy and idiopathic hypersomnia remain underdiagnosed or are often diagnosed after prolonged delays, leaving additional treatment demand to be released as physician awareness, referral pathways, and patient education improve. Severe spasticity also creates sustained demand for individualized and long-term treatment, supporting continued use of intrathecal baclofen and differentiated oral formulations. Broader reimbursement coverage, improved commercial insurance access, and stronger specialist treatment infrastructure may further increase patient access to high-value products. In emerging markets, demand growth is expected to rely more heavily on generic baclofen availability, hospital coverage, and improvements in neurological care capacity.
The industry nevertheless faces significant regulatory, pricing, and substitution risks. Oxybate medicines are controlled central nervous system products and require strict prescribing, risk management, specialist distribution, and patient monitoring, which limits rapid expansion through conventional channels. The entry of authorized and conventional generics is expected to improve treatment access but will place downward pressure on the pricing and market share of established branded products. Conventional baclofen formulations face product commoditization, centralized procurement, and low-price competition, while intrathecal therapy remains constrained by procedure complexity and the availability of trained treatment centers. In the longer term, orexin receptor agonists, other wake-promoting medicines, and new treatment approaches for spasticity may divert part of existing demand. Competitive advantage will therefore increasingly depend on differentiated formulations, clinical evidence, reimbursement access, specialist distribution, supply reliability, and patient-management capabilities.
LPI (LP Information)' newest research report, the “?-Aminobutyric Acid Receptor Agonists Industry Forecast” looks at past sales and reviews total world ?-Aminobutyric Acid Receptor Agonists sales in 2025, providing a comprehensive analysis by region and market sector of projected ?-Aminobutyric Acid Receptor Agonists sales for 2026 through 2032. With ?-Aminobutyric Acid Receptor Agonists sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ?-Aminobutyric Acid Receptor Agonists industry.
This Insight Report provides a comprehensive analysis of the global ?-Aminobutyric Acid Receptor Agonists landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on ?-Aminobutyric Acid Receptor Agonists portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ?-Aminobutyric Acid Receptor Agonists market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ?-Aminobutyric Acid Receptor Agonists and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ?-Aminobutyric Acid Receptor Agonists.
This report presents a comprehensive overview, market shares, and growth opportunities of ?-Aminobutyric Acid Receptor Agonists market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Baclofen
- Sodium Oxybate
- Mixed Oxybate Salts
- Other
Segmentation by Dosage Form:
- Oral Solid Dosage Forms
- Immediate-release Oral Liquids
- Other
Segmentation by Product Status:
- Branded Drugs
- Generic Drugs
Segmentation by Application:
- Hospitals
- Clinics
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Jazz Pharmaceuticals
- Alkermes
- Hikma Pharmaceuticals
- Amneal Pharmaceuticals
- Piramal Pharma
- Azurity Pharmaceuticals
- Sagent Pharmaceuticals
- Novartis
- Daiichi Sankyo
- Fuan Pharmaceutical Group
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global ?-Aminobutyric Acid Receptor Agonists Market Size (2021-2032)
2.1.2 ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for ?-Aminobutyric Acid Receptor Agonists by Country/Region (2021, 2025 & 2032)
2.2 ?-Aminobutyric Acid Receptor Agonists Segment by Type
2.2.1 Baclofen
2.2.2 Sodium Oxybate
2.2.3 Mixed Oxybate Salts
2.2.4 Other
2.2.5 ?-Aminobutyric Acid Receptor Agonists Market Size by Type
2.2.5.1 ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type (2021-2026)
2.3 ?-Aminobutyric Acid Receptor Agonists Segment by Dosage Form
2.3.1 Oral Solid Dosage Forms
2.3.2 Immediate-release Oral Liquids
2.3.3 Other
2.3.4 ?-Aminobutyric Acid Receptor Agonists Market Size by Dosage Form
2.3.4.1 ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Dosage Form (2021 VS 2025 VS 2032)
2.3.4.2 Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Dosage Form (2021-2026)
2.4 ?-Aminobutyric Acid Receptor Agonists Segment by Product Status
2.4.1 Branded Drugs
2.4.2 Generic Drugs
2.4.3 ?-Aminobutyric Acid Receptor Agonists Market Size by Product Status
2.4.3.1 ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Product Status (2021 VS 2025 VS 2032)
2.4.3.2 Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Product Status (2021-2026)
2.5 ?-Aminobutyric Acid Receptor Agonists Segment by Application
2.5.1 Hospitals
2.5.2 Clinics
2.5.3 Other
2.5.4 ?-Aminobutyric Acid Receptor Agonists Market Size by Application
2.5.4.1 ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application (2021-2026)
3 ?-AMINOBUTYRIC ACID RECEPTOR AGONISTS MARKET SIZE BY PLAYER
3.1 ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Player
3.1.1 Global ?-Aminobutyric Acid Receptor Agonists Revenue by Player (2021-2026)
3.1.2 Global ?-Aminobutyric Acid Receptor Agonists Revenue Market Share by Player (2021-2026)
3.2 Global ?-Aminobutyric Acid Receptor Agonists Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ?-AMINOBUTYRIC ACID RECEPTOR AGONISTS BY REGION
4.1 ?-Aminobutyric Acid Receptor Agonists Market Size by Region (2021-2026)
4.2 Global ?-Aminobutyric Acid Receptor Agonists Annual Revenue by Country/Region (2021-2026)
4.3 Americas ?-Aminobutyric Acid Receptor Agonists Market Size Growth (2021-2026)
4.4 APAC ?-Aminobutyric Acid Receptor Agonists Market Size Growth (2021-2026)
4.5 Europe ?-Aminobutyric Acid Receptor Agonists Market Size Growth (2021-2026)
4.6 Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas ?-Aminobutyric Acid Receptor Agonists Market Size by Country (2021-2026)
5.2 Americas ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026)
5.3 Americas ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC ?-Aminobutyric Acid Receptor Agonists Market Size by Region (2021-2026)
6.2 APAC ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026)
6.3 APAC ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe ?-Aminobutyric Acid Receptor Agonists Market Size by Country (2021-2026)
7.2 Europe ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026)
7.3 Europe ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa ?-Aminobutyric Acid Receptor Agonists by Region (2021-2026)
8.2 Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026)
8.3 Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ?-AMINOBUTYRIC ACID RECEPTOR AGONISTS MARKET FORECAST
10.1 Global ?-Aminobutyric Acid Receptor Agonists Forecast by Region (2027-2032)
10.1.1 Global ?-Aminobutyric Acid Receptor Agonists Forecast by Region (2027-2032)
10.1.2 Americas ?-Aminobutyric Acid Receptor Agonists Forecast
10.1.3 APAC ?-Aminobutyric Acid Receptor Agonists Forecast
10.1.4 Europe ?-Aminobutyric Acid Receptor Agonists Forecast
10.1.5 Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Forecast
10.2 Americas ?-Aminobutyric Acid Receptor Agonists Forecast by Country (2027-2032)
10.2.1 United States Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.2.2 Canada Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.2.3 Mexico Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.2.4 Brazil Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.3 APAC ?-Aminobutyric Acid Receptor Agonists Forecast by Region (2027-2032)
10.3.1 China ?-Aminobutyric Acid Receptor Agonists Market Forecast
10.3.2 Japan Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.3.3 Korea Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.3.4 Southeast Asia Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.3.5 India Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.3.6 Australia Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.4 Europe ?-Aminobutyric Acid Receptor Agonists Forecast by Country (2027-2032)
10.4.1 Germany Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.4.2 France Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.4.3 UK Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.4.4 Italy Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.4.5 Russia Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.5 Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Forecast by Region (2027-2032)
10.5.1 Egypt Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.5.2 South Africa Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.5.3 Israel Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.5.4 Turkey Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.6 Global ?-Aminobutyric Acid Receptor Agonists Forecast by Type (2027-2032)
10.7 Global ?-Aminobutyric Acid Receptor Agonists Forecast by Application (2027-2032)
10.7.1 GCC Countries Market ?-Aminobutyric Acid Receptor Agonists Forecast
11 KEY PLAYERS ANALYSIS
11.1 Jazz Pharmaceuticals
11.1.1 Jazz Pharmaceuticals Company Information
11.1.2 Jazz Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
11.1.3 Jazz Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Jazz Pharmaceuticals Main Business Overview
11.1.5 Jazz Pharmaceuticals Latest Developments
11.2 Alkermes
11.2.1 Alkermes Company Information
11.2.2 Alkermes ?-Aminobutyric Acid Receptor Agonists Product Offered
11.2.3 Alkermes ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Alkermes Main Business Overview
11.2.5 Alkermes Latest Developments
11.3 Hikma Pharmaceuticals
11.3.1 Hikma Pharmaceuticals Company Information
11.3.2 Hikma Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
11.3.3 Hikma Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Hikma Pharmaceuticals Main Business Overview
11.3.5 Hikma Pharmaceuticals Latest Developments
11.4 Amneal Pharmaceuticals
11.4.1 Amneal Pharmaceuticals Company Information
11.4.2 Amneal Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
11.4.3 Amneal Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Amneal Pharmaceuticals Main Business Overview
11.4.5 Amneal Pharmaceuticals Latest Developments
11.5 Piramal Pharma
11.5.1 Piramal Pharma Company Information
11.5.2 Piramal Pharma ?-Aminobutyric Acid Receptor Agonists Product Offered
11.5.3 Piramal Pharma ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Piramal Pharma Main Business Overview
11.5.5 Piramal Pharma Latest Developments
11.6 Azurity Pharmaceuticals
11.6.1 Azurity Pharmaceuticals Company Information
11.6.2 Azurity Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
11.6.3 Azurity Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Azurity Pharmaceuticals Main Business Overview
11.6.5 Azurity Pharmaceuticals Latest Developments
11.7 Sagent Pharmaceuticals
11.7.1 Sagent Pharmaceuticals Company Information
11.7.2 Sagent Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
11.7.3 Sagent Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Sagent Pharmaceuticals Main Business Overview
11.7.5 Sagent Pharmaceuticals Latest Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis ?-Aminobutyric Acid Receptor Agonists Product Offered
11.8.3 Novartis ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Novartis Main Business Overview
11.8.5 Novartis Latest Developments
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Information
11.9.2 Daiichi Sankyo ?-Aminobutyric Acid Receptor Agonists Product Offered
11.9.3 Daiichi Sankyo ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Daiichi Sankyo Main Business Overview
11.9.5 Daiichi Sankyo Latest Developments
11.10 Fuan Pharmaceutical Group
11.10.1 Fuan Pharmaceutical Group Company Information
11.10.2 Fuan Pharmaceutical Group ?-Aminobutyric Acid Receptor Agonists Product Offered
11.10.3 Fuan Pharmaceutical Group ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Fuan Pharmaceutical Group Main Business Overview
11.10.5 Fuan Pharmaceutical Group Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global ?-Aminobutyric Acid Receptor Agonists Market Size (2021-2032)
2.1.2 ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for ?-Aminobutyric Acid Receptor Agonists by Country/Region (2021, 2025 & 2032)
2.2 ?-Aminobutyric Acid Receptor Agonists Segment by Type
2.2.1 Baclofen
2.2.2 Sodium Oxybate
2.2.3 Mixed Oxybate Salts
2.2.4 Other
2.2.5 ?-Aminobutyric Acid Receptor Agonists Market Size by Type
2.2.5.1 ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type (2021-2026)
2.3 ?-Aminobutyric Acid Receptor Agonists Segment by Dosage Form
2.3.1 Oral Solid Dosage Forms
2.3.2 Immediate-release Oral Liquids
2.3.3 Other
2.3.4 ?-Aminobutyric Acid Receptor Agonists Market Size by Dosage Form
2.3.4.1 ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Dosage Form (2021 VS 2025 VS 2032)
2.3.4.2 Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Dosage Form (2021-2026)
2.4 ?-Aminobutyric Acid Receptor Agonists Segment by Product Status
2.4.1 Branded Drugs
2.4.2 Generic Drugs
2.4.3 ?-Aminobutyric Acid Receptor Agonists Market Size by Product Status
2.4.3.1 ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Product Status (2021 VS 2025 VS 2032)
2.4.3.2 Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Product Status (2021-2026)
2.5 ?-Aminobutyric Acid Receptor Agonists Segment by Application
2.5.1 Hospitals
2.5.2 Clinics
2.5.3 Other
2.5.4 ?-Aminobutyric Acid Receptor Agonists Market Size by Application
2.5.4.1 ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application (2021-2026)
3 ?-AMINOBUTYRIC ACID RECEPTOR AGONISTS MARKET SIZE BY PLAYER
3.1 ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Player
3.1.1 Global ?-Aminobutyric Acid Receptor Agonists Revenue by Player (2021-2026)
3.1.2 Global ?-Aminobutyric Acid Receptor Agonists Revenue Market Share by Player (2021-2026)
3.2 Global ?-Aminobutyric Acid Receptor Agonists Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ?-AMINOBUTYRIC ACID RECEPTOR AGONISTS BY REGION
4.1 ?-Aminobutyric Acid Receptor Agonists Market Size by Region (2021-2026)
4.2 Global ?-Aminobutyric Acid Receptor Agonists Annual Revenue by Country/Region (2021-2026)
4.3 Americas ?-Aminobutyric Acid Receptor Agonists Market Size Growth (2021-2026)
4.4 APAC ?-Aminobutyric Acid Receptor Agonists Market Size Growth (2021-2026)
4.5 Europe ?-Aminobutyric Acid Receptor Agonists Market Size Growth (2021-2026)
4.6 Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas ?-Aminobutyric Acid Receptor Agonists Market Size by Country (2021-2026)
5.2 Americas ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026)
5.3 Americas ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC ?-Aminobutyric Acid Receptor Agonists Market Size by Region (2021-2026)
6.2 APAC ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026)
6.3 APAC ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe ?-Aminobutyric Acid Receptor Agonists Market Size by Country (2021-2026)
7.2 Europe ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026)
7.3 Europe ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa ?-Aminobutyric Acid Receptor Agonists by Region (2021-2026)
8.2 Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026)
8.3 Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ?-AMINOBUTYRIC ACID RECEPTOR AGONISTS MARKET FORECAST
10.1 Global ?-Aminobutyric Acid Receptor Agonists Forecast by Region (2027-2032)
10.1.1 Global ?-Aminobutyric Acid Receptor Agonists Forecast by Region (2027-2032)
10.1.2 Americas ?-Aminobutyric Acid Receptor Agonists Forecast
10.1.3 APAC ?-Aminobutyric Acid Receptor Agonists Forecast
10.1.4 Europe ?-Aminobutyric Acid Receptor Agonists Forecast
10.1.5 Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Forecast
10.2 Americas ?-Aminobutyric Acid Receptor Agonists Forecast by Country (2027-2032)
10.2.1 United States Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.2.2 Canada Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.2.3 Mexico Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.2.4 Brazil Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.3 APAC ?-Aminobutyric Acid Receptor Agonists Forecast by Region (2027-2032)
10.3.1 China ?-Aminobutyric Acid Receptor Agonists Market Forecast
10.3.2 Japan Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.3.3 Korea Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.3.4 Southeast Asia Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.3.5 India Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.3.6 Australia Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.4 Europe ?-Aminobutyric Acid Receptor Agonists Forecast by Country (2027-2032)
10.4.1 Germany Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.4.2 France Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.4.3 UK Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.4.4 Italy Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.4.5 Russia Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.5 Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Forecast by Region (2027-2032)
10.5.1 Egypt Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.5.2 South Africa Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.5.3 Israel Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.5.4 Turkey Market ?-Aminobutyric Acid Receptor Agonists Forecast
10.6 Global ?-Aminobutyric Acid Receptor Agonists Forecast by Type (2027-2032)
10.7 Global ?-Aminobutyric Acid Receptor Agonists Forecast by Application (2027-2032)
10.7.1 GCC Countries Market ?-Aminobutyric Acid Receptor Agonists Forecast
11 KEY PLAYERS ANALYSIS
11.1 Jazz Pharmaceuticals
11.1.1 Jazz Pharmaceuticals Company Information
11.1.2 Jazz Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
11.1.3 Jazz Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Jazz Pharmaceuticals Main Business Overview
11.1.5 Jazz Pharmaceuticals Latest Developments
11.2 Alkermes
11.2.1 Alkermes Company Information
11.2.2 Alkermes ?-Aminobutyric Acid Receptor Agonists Product Offered
11.2.3 Alkermes ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Alkermes Main Business Overview
11.2.5 Alkermes Latest Developments
11.3 Hikma Pharmaceuticals
11.3.1 Hikma Pharmaceuticals Company Information
11.3.2 Hikma Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
11.3.3 Hikma Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Hikma Pharmaceuticals Main Business Overview
11.3.5 Hikma Pharmaceuticals Latest Developments
11.4 Amneal Pharmaceuticals
11.4.1 Amneal Pharmaceuticals Company Information
11.4.2 Amneal Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
11.4.3 Amneal Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Amneal Pharmaceuticals Main Business Overview
11.4.5 Amneal Pharmaceuticals Latest Developments
11.5 Piramal Pharma
11.5.1 Piramal Pharma Company Information
11.5.2 Piramal Pharma ?-Aminobutyric Acid Receptor Agonists Product Offered
11.5.3 Piramal Pharma ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Piramal Pharma Main Business Overview
11.5.5 Piramal Pharma Latest Developments
11.6 Azurity Pharmaceuticals
11.6.1 Azurity Pharmaceuticals Company Information
11.6.2 Azurity Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
11.6.3 Azurity Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Azurity Pharmaceuticals Main Business Overview
11.6.5 Azurity Pharmaceuticals Latest Developments
11.7 Sagent Pharmaceuticals
11.7.1 Sagent Pharmaceuticals Company Information
11.7.2 Sagent Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
11.7.3 Sagent Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Sagent Pharmaceuticals Main Business Overview
11.7.5 Sagent Pharmaceuticals Latest Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis ?-Aminobutyric Acid Receptor Agonists Product Offered
11.8.3 Novartis ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Novartis Main Business Overview
11.8.5 Novartis Latest Developments
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Information
11.9.2 Daiichi Sankyo ?-Aminobutyric Acid Receptor Agonists Product Offered
11.9.3 Daiichi Sankyo ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Daiichi Sankyo Main Business Overview
11.9.5 Daiichi Sankyo Latest Developments
11.10 Fuan Pharmaceutical Group
11.10.1 Fuan Pharmaceutical Group Company Information
11.10.2 Fuan Pharmaceutical Group ?-Aminobutyric Acid Receptor Agonists Product Offered
11.10.3 Fuan Pharmaceutical Group ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Fuan Pharmaceutical Group Main Business Overview
11.10.5 Fuan Pharmaceutical Group Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. ?-Aminobutyric Acid Receptor Agonists Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Baclofen
Table 4. Major Players of Sodium Oxybate
Table 5. Major Players of Mixed Oxybate Salts
Table 6. Major Players of Other
Table 7. ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 9. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Oral Solid Dosage Forms
Table 11. Major Players of Immediate-release Oral Liquids
Table 12. Major Players of Other
Table 13. ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Dosage Form (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global ?-Aminobutyric Acid Receptor Agonists Market Size by Dosage Form (2021-2026) & ($ millions)
Table 15. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Dosage Form (2021-2026)
Table 16. Major Players of Branded Drugs
Table 17. Major Players of Generic Drugs
Table 18. ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Product Status (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global ?-Aminobutyric Acid Receptor Agonists Market Size by Product Status (2021-2026) & ($ millions)
Table 20. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Product Status (2021-2026)
Table 21. ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 23. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application (2021-2026)
Table 24. Global ?-Aminobutyric Acid Receptor Agonists Revenue by Player (2021-2026) & ($ millions)
Table 25. Global ?-Aminobutyric Acid Receptor Agonists Revenue Market Share by Player (2021-2026)
Table 26. ?-Aminobutyric Acid Receptor Agonists Key Players Head office and Products Offered
Table 27. ?-Aminobutyric Acid Receptor Agonists Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global ?-Aminobutyric Acid Receptor Agonists Market Size by Region (2021-2026) & ($ millions)
Table 31. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Region (2021-2026)
Table 32. Global ?-Aminobutyric Acid Receptor Agonists Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global ?-Aminobutyric Acid Receptor Agonists Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas ?-Aminobutyric Acid Receptor Agonists Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Country (2021-2026)
Table 36. Americas ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type (2021-2026)
Table 38. Americas ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application (2021-2026)
Table 40. APAC ?-Aminobutyric Acid Receptor Agonists Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Region (2021-2026)
Table 42. APAC ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe ?-Aminobutyric Acid Receptor Agonists Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Country (2021-2026)
Table 46. Europe ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of ?-Aminobutyric Acid Receptor Agonists
Table 52. Key Market Challenges & Risks of ?-Aminobutyric Acid Receptor Agonists
Table 53. Key Industry Trends of ?-Aminobutyric Acid Receptor Agonists
Table 54. Global ?-Aminobutyric Acid Receptor Agonists Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global ?-Aminobutyric Acid Receptor Agonists Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global ?-Aminobutyric Acid Receptor Agonists Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Jazz Pharmaceuticals Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 59. Jazz Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 60. Jazz Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Jazz Pharmaceuticals Main Business
Table 62. Jazz Pharmaceuticals Latest Developments
Table 63. Alkermes Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 64. Alkermes ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 65. Alkermes ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Alkermes Main Business
Table 67. Alkermes Latest Developments
Table 68. Hikma Pharmaceuticals Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 69. Hikma Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 70. Hikma Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Hikma Pharmaceuticals Main Business
Table 72. Hikma Pharmaceuticals Latest Developments
Table 73. Amneal Pharmaceuticals Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 74. Amneal Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 75. Amneal Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Amneal Pharmaceuticals Main Business
Table 77. Amneal Pharmaceuticals Latest Developments
Table 78. Piramal Pharma Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 79. Piramal Pharma ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 80. Piramal Pharma ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Piramal Pharma Main Business
Table 82. Piramal Pharma Latest Developments
Table 83. Azurity Pharmaceuticals Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 84. Azurity Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 85. Azurity Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Azurity Pharmaceuticals Main Business
Table 87. Azurity Pharmaceuticals Latest Developments
Table 88. Sagent Pharmaceuticals Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 89. Sagent Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 90. Sagent Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Sagent Pharmaceuticals Main Business
Table 92. Sagent Pharmaceuticals Latest Developments
Table 93. Novartis Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 94. Novartis ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 95. Novartis ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Novartis Main Business
Table 97. Novartis Latest Developments
Table 98. Daiichi Sankyo Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 99. Daiichi Sankyo ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 100. Daiichi Sankyo ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Daiichi Sankyo Main Business
Table 102. Daiichi Sankyo Latest Developments
Table 103. Fuan Pharmaceutical Group Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 104. Fuan Pharmaceutical Group ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 105. Fuan Pharmaceutical Group ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Fuan Pharmaceutical Group Main Business
Table 107. Fuan Pharmaceutical Group Latest Developments
Table 1. ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. ?-Aminobutyric Acid Receptor Agonists Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Baclofen
Table 4. Major Players of Sodium Oxybate
Table 5. Major Players of Mixed Oxybate Salts
Table 6. Major Players of Other
Table 7. ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 9. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Oral Solid Dosage Forms
Table 11. Major Players of Immediate-release Oral Liquids
Table 12. Major Players of Other
Table 13. ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Dosage Form (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global ?-Aminobutyric Acid Receptor Agonists Market Size by Dosage Form (2021-2026) & ($ millions)
Table 15. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Dosage Form (2021-2026)
Table 16. Major Players of Branded Drugs
Table 17. Major Players of Generic Drugs
Table 18. ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Product Status (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global ?-Aminobutyric Acid Receptor Agonists Market Size by Product Status (2021-2026) & ($ millions)
Table 20. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Product Status (2021-2026)
Table 21. ?-Aminobutyric Acid Receptor Agonists Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 23. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application (2021-2026)
Table 24. Global ?-Aminobutyric Acid Receptor Agonists Revenue by Player (2021-2026) & ($ millions)
Table 25. Global ?-Aminobutyric Acid Receptor Agonists Revenue Market Share by Player (2021-2026)
Table 26. ?-Aminobutyric Acid Receptor Agonists Key Players Head office and Products Offered
Table 27. ?-Aminobutyric Acid Receptor Agonists Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global ?-Aminobutyric Acid Receptor Agonists Market Size by Region (2021-2026) & ($ millions)
Table 31. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Region (2021-2026)
Table 32. Global ?-Aminobutyric Acid Receptor Agonists Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global ?-Aminobutyric Acid Receptor Agonists Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas ?-Aminobutyric Acid Receptor Agonists Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Country (2021-2026)
Table 36. Americas ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type (2021-2026)
Table 38. Americas ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application (2021-2026)
Table 40. APAC ?-Aminobutyric Acid Receptor Agonists Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Region (2021-2026)
Table 42. APAC ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe ?-Aminobutyric Acid Receptor Agonists Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Country (2021-2026)
Table 46. Europe ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of ?-Aminobutyric Acid Receptor Agonists
Table 52. Key Market Challenges & Risks of ?-Aminobutyric Acid Receptor Agonists
Table 53. Key Industry Trends of ?-Aminobutyric Acid Receptor Agonists
Table 54. Global ?-Aminobutyric Acid Receptor Agonists Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global ?-Aminobutyric Acid Receptor Agonists Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global ?-Aminobutyric Acid Receptor Agonists Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Jazz Pharmaceuticals Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 59. Jazz Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 60. Jazz Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Jazz Pharmaceuticals Main Business
Table 62. Jazz Pharmaceuticals Latest Developments
Table 63. Alkermes Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 64. Alkermes ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 65. Alkermes ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Alkermes Main Business
Table 67. Alkermes Latest Developments
Table 68. Hikma Pharmaceuticals Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 69. Hikma Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 70. Hikma Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Hikma Pharmaceuticals Main Business
Table 72. Hikma Pharmaceuticals Latest Developments
Table 73. Amneal Pharmaceuticals Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 74. Amneal Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 75. Amneal Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Amneal Pharmaceuticals Main Business
Table 77. Amneal Pharmaceuticals Latest Developments
Table 78. Piramal Pharma Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 79. Piramal Pharma ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 80. Piramal Pharma ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Piramal Pharma Main Business
Table 82. Piramal Pharma Latest Developments
Table 83. Azurity Pharmaceuticals Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 84. Azurity Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 85. Azurity Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Azurity Pharmaceuticals Main Business
Table 87. Azurity Pharmaceuticals Latest Developments
Table 88. Sagent Pharmaceuticals Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 89. Sagent Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 90. Sagent Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Sagent Pharmaceuticals Main Business
Table 92. Sagent Pharmaceuticals Latest Developments
Table 93. Novartis Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 94. Novartis ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 95. Novartis ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Novartis Main Business
Table 97. Novartis Latest Developments
Table 98. Daiichi Sankyo Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 99. Daiichi Sankyo ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 100. Daiichi Sankyo ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Daiichi Sankyo Main Business
Table 102. Daiichi Sankyo Latest Developments
Table 103. Fuan Pharmaceutical Group Details, Company Type, ?-Aminobutyric Acid Receptor Agonists Area Served and Its Competitors
Table 104. Fuan Pharmaceutical Group ?-Aminobutyric Acid Receptor Agonists Product Offered
Table 105. Fuan Pharmaceutical Group ?-Aminobutyric Acid Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Fuan Pharmaceutical Group Main Business
Table 107. Fuan Pharmaceutical Group Latest Developments
LIST OF FIGURES
Figure 1. ?-Aminobutyric Acid Receptor Agonists Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global ?-Aminobutyric Acid Receptor Agonists Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. ?-Aminobutyric Acid Receptor Agonists Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. ?-Aminobutyric Acid Receptor Agonists Sales Market Share by Country/Region (2025)
Figure 8. ?-Aminobutyric Acid Receptor Agonists Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type in 2025
Figure 10. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Dosage Form in 2025
Figure 11. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Product Status in 2025
Figure 12. ?-Aminobutyric Acid Receptor Agonists in Hospitals
Figure 13. Global ?-Aminobutyric Acid Receptor Agonists Market: Hospitals (2021-2026) & ($ millions)
Figure 14. ?-Aminobutyric Acid Receptor Agonists in Clinics
Figure 15. Global ?-Aminobutyric Acid Receptor Agonists Market: Clinics (2021-2026) & ($ millions)
Figure 16. ?-Aminobutyric Acid Receptor Agonists in Other
Figure 17. Global ?-Aminobutyric Acid Receptor Agonists Market: Other (2021-2026) & ($ millions)
Figure 18. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application in 2025
Figure 19. Global ?-Aminobutyric Acid Receptor Agonists Revenue Market Share by Player in 2025
Figure 20. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Region (2021-2026)
Figure 21. Americas ?-Aminobutyric Acid Receptor Agonists Market Size 2021-2026 ($ millions)
Figure 22. APAC ?-Aminobutyric Acid Receptor Agonists Market Size 2021-2026 ($ millions)
Figure 23. Europe ?-Aminobutyric Acid Receptor Agonists Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size 2021-2026 ($ millions)
Figure 25. Americas ?-Aminobutyric Acid Receptor Agonists Value Market Share by Country in 2025
Figure 26. United States ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Region in 2025
Figure 31. APAC ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type (2021-2026)
Figure 32. APAC ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application (2021-2026)
Figure 33. China ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 37. India ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Country in 2025
Figure 40. Europe ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type (2021-2026)
Figure 41. Europe ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application (2021-2026)
Figure 42. Germany ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 43. France ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 44. UK ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application (2021-2026)
Figure 50. Egypt ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 56. APAC ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 57. Europe ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 59. United States ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 60. Canada ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 61. Mexico ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 62. Brazil ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 63. China ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 64. Japan ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 65. Korea ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 67. India ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 68. Australia ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 69. Germany ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 70. France ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 71. UK ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 72. Italy ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 73. Russia ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 74. Egypt ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 75. South Africa ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 76. Israel ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 77. Turkey ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 78. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 1. ?-Aminobutyric Acid Receptor Agonists Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global ?-Aminobutyric Acid Receptor Agonists Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. ?-Aminobutyric Acid Receptor Agonists Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. ?-Aminobutyric Acid Receptor Agonists Sales Market Share by Country/Region (2025)
Figure 8. ?-Aminobutyric Acid Receptor Agonists Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type in 2025
Figure 10. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Dosage Form in 2025
Figure 11. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Product Status in 2025
Figure 12. ?-Aminobutyric Acid Receptor Agonists in Hospitals
Figure 13. Global ?-Aminobutyric Acid Receptor Agonists Market: Hospitals (2021-2026) & ($ millions)
Figure 14. ?-Aminobutyric Acid Receptor Agonists in Clinics
Figure 15. Global ?-Aminobutyric Acid Receptor Agonists Market: Clinics (2021-2026) & ($ millions)
Figure 16. ?-Aminobutyric Acid Receptor Agonists in Other
Figure 17. Global ?-Aminobutyric Acid Receptor Agonists Market: Other (2021-2026) & ($ millions)
Figure 18. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application in 2025
Figure 19. Global ?-Aminobutyric Acid Receptor Agonists Revenue Market Share by Player in 2025
Figure 20. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Region (2021-2026)
Figure 21. Americas ?-Aminobutyric Acid Receptor Agonists Market Size 2021-2026 ($ millions)
Figure 22. APAC ?-Aminobutyric Acid Receptor Agonists Market Size 2021-2026 ($ millions)
Figure 23. Europe ?-Aminobutyric Acid Receptor Agonists Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size 2021-2026 ($ millions)
Figure 25. Americas ?-Aminobutyric Acid Receptor Agonists Value Market Share by Country in 2025
Figure 26. United States ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Region in 2025
Figure 31. APAC ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type (2021-2026)
Figure 32. APAC ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application (2021-2026)
Figure 33. China ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 37. India ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Country in 2025
Figure 40. Europe ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type (2021-2026)
Figure 41. Europe ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application (2021-2026)
Figure 42. Germany ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 43. France ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 44. UK ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application (2021-2026)
Figure 50. Egypt ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries ?-Aminobutyric Acid Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 56. APAC ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 57. Europe ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 59. United States ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 60. Canada ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 61. Mexico ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 62. Brazil ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 63. China ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 64. Japan ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 65. Korea ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 67. India ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 68. Australia ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 69. Germany ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 70. France ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 71. UK ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 72. Italy ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 73. Russia ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 74. Egypt ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 75. South Africa ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 76. Israel ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 77. Turkey ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 78. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global ?-Aminobutyric Acid Receptor Agonists Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries ?-Aminobutyric Acid Receptor Agonists Market Size 2027-2032 ($ millions)
